Drug discovery
Introduction
The developing world suffers the major burden of infectious disease, yet the range of drugs available for the treatment of many infectious diseases is limited. Moreover, some currently available drugs are difficult to access or administer in developing country settings, while others remain unaffordable at the patient or health facility level; meanwhile, there is increasing resistance to some drugs. Many new public-private partnerships are developing new drugs for the diseases of poverty and they need new leads to work from.
TDR related research
TDR supports research on this topic. Our work is being conducted in the following areas:
- Soil-transmitted helminth drug candidates
-
The African Network for Drugs and Diagnostics Initiative (ANDI)
ANDI has been established at the United Nations Economic Commission for Africa (UNECA) in Addis Ababa, Ethiopia, to initiate and increase both drug discovery and development on the African continent.
Latest news
-
WHO releases first global report on neglected tropical diseases
14 October 2010 -
The Race Against Drug Resistance
24 June 2010
TDR publications and articles
-
TDR Performance assessment framework
Measuring results
10 August 2011 -
Indicators for monitoring and evaluation of the kala-azar elimination programme
Kala-azar elimination in Bangladesh, India and Nepal
21 October 2010 -
Monitoring and evaluation tool kit for indoor residual spraying
Kala-azar elimination in Bangladesh, India and Nepal
21 October 2010